Kyverna Therapeutics
KYTX
KYTX
99 hedge funds and large institutions have $321M invested in Kyverna Therapeutics in 2025 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% more funds holding
Funds holding: 75 → 99 (+24)
25.45% more ownership
Funds ownership: 52.48% → 77.93% (+25%)
19% less call options, than puts
Call options by funds: $967K | Put options by funds: $1.19M
Holders
99
Holding in Top 10
6
Calls
$967K
Puts
$1.19M
Top Buyers
| 1 | +$14.8M | |
| 2 | +$12.4M | |
| 3 | +$11.1M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.28M |
| 5 |
Morgan Stanley
New York
|
+$6.15M |
Top Sellers
| 1 | -$4.07M | |
| 2 | -$3.52M | |
| 3 | -$2.15M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$1.92M |
| 5 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
-$1M |
